Evidence map›Paper›PMID 36201226›Full record

ArticleAIDS patient care and STDs2022

Providers' Attitudes and Experiences with Pre-Exposure Prophylaxis Implementation in a Population-Based Study in Kenya and Uganda.

Carol S Camlin, Monica Getahun, Catherine A Koss, Lawrence Owino, Cecilia Akatukwasa, Harriet Itiakorit, Anjeline Onyango, Robert Bakanoma, Fredrick Atwine, Irene Maeri and 14 more

Registry-linked trialAbstract read
In one paragraph

Article in AIDS patient care and STDs, 2022. The graph could read no effect estimate from its abstract, so it casts no vote on the map. It is linked to trial NCT01864603 (Sustainable East Africa Research in Community Health), which is not on this map. Cited by 10 papers, 1 of them a synthesis that pooled it.

0numbers the graph read from it
0cells of the map it votes in
10citing papers in PubMed, 1 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

NCT01864603 nacompletednot on this map

Sustainable East Africa Research in Community Health

TypeinterventionalSponsorUniversity of California, San FranciscoRan2013 to 2021Enrolled150,395ConditionsHIV, Tuberculosis, Hypertension, DiabetesArmsUniversal ART in a streamlined care model, Annual Community Health Campaigns, Targeted PrEP and Targeted testing interventions, Baseline community-based HIV and multi-disease testing
3 · Its place in the literature

Who cites it

10 citing papers in PubMed, 1 synthesis or guideline pooled it.

  1. Pooled it
  2. Article
  3. Article
  4. Article
  5. Article
  6. Article
  7. Article
  8. Article
  9. Lenacapavir for HIV Prevention in Africa: Opportunities, Barriers, and Policy Priorities.Journal of the International Association of Providers of AIDS Care
    Review
  10. Review
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

24 authors.

Carol S CamlinDepartment of Obstetrics, Gynecology, & Reproductive Sciences, University of California, San Francisco (UCSF), San Francisco, California, USA.ORCID 0000-0001-5615-1164
Monica GetahunDepartment of Obstetrics, Gynecology, & Reproductive Sciences, University of California, San Francisco (UCSF), San Francisco, California, USA.
Catherine A KossDivision of HIV, Infectious Diseases & Global Medicine, Department of Medicine, University of California, San Francisco (UCSF), San Francisco, California, USA.
Lawrence OwinoKenya Medical Research Institute (KEMRI), Nairobi, Kenya.
Cecilia AkatukwasaInfectious Diseases Research Collaboration (IDRC), Kampala, Uganda.
Harriet ItiakoritInfectious Diseases Research Collaboration (IDRC), Kampala, Uganda.
Anjeline OnyangoKenya Medical Research Institute (KEMRI), Nairobi, Kenya.
Robert BakanomaInfectious Diseases Research Collaboration (IDRC), Kampala, Uganda.
Fredrick AtwineInfectious Diseases Research Collaboration (IDRC), Kampala, Uganda.
Irene MaeriKenya Medical Research Institute (KEMRI), Nairobi, Kenya.
James AyiekoKenya Medical Research Institute (KEMRI), Nairobi, Kenya.
Mucunguzi AtukundaInfectious Diseases Research Collaboration (IDRC), Kampala, Uganda.
Asiphas OwaraganiseInfectious Diseases Research Collaboration (IDRC), Kampala, Uganda.
Florence MwangwaInfectious Diseases Research Collaboration (IDRC), Kampala, Uganda.
Norton SangKenya Medical Research Institute (KEMRI), Nairobi, Kenya.
Jane KabamiInfectious Diseases Research Collaboration (IDRC), Kampala, Uganda.
Rachel L KaplanDepartment of Obstetrics, Gynecology, & Reproductive Sciences, University of California, San Francisco (UCSF), San Francisco, California, USA.
Gabriel ChamieDivision of HIV, Infectious Diseases & Global Medicine, Department of Medicine, University of California, San Francisco (UCSF), San Francisco, California, USA.
Maya L PetersenDivisions of Biostatistics & Epidemiology, School of Public Health, University of California, Berkeley, Berkeley, California, USA.
Craig R CohenDepartment of Obstetrics, Gynecology, & Reproductive Sciences, University of California, San Francisco (UCSF), San Francisco, California, USA.
Elizabeth A BukusiKenya Medical Research Institute (KEMRI), Nairobi, Kenya.
Moses R KamyaInfectious Diseases Research Collaboration (IDRC), Kampala, Uganda.
Diane V HavlirDivision of HIV, Infectious Diseases & Global Medicine, Department of Medicine, University of California, San Francisco (UCSF), San Francisco, California, USA.
Edwin D CharleboisDepartment of Medicine, Center for AIDS Prevention Studies, University of California, San Francisco (UCSF), San Francisco, California, USA.ORCID 0000-0001-7237-2119

Funding

Leadership and Operations Center (LOC), AIDS Clinical Trials Group (ACTG); LOC 1/UM1AI068636 · NIAID · UNIV OF NORTH CAROLINA CHAPEL HILL · PI Joseph J Eron, RAJESH T GANDHI · 2011 to 2026
$1073.1M
Reducing Failure-to-Initiate ART: Streamlined ART Start Strategy (START)U01AI099959 · NIAID · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI HAVLIR, DIANE V · 2012 to 2016
$39.7M
Optimizing Adherence to PrEP among Young African Women through a Community Adherence Club InterventionK23MH114760 · NIMH · UNIVERSITY OF CALIFORNIA, SAN FRANCISCO · PI KOSS, CATHERINE ANNE STIMETS · 2018 to 2021
$796k
NIAID NIH HHS U01 AI099959NIAID NIH HHS UM1 AI068636NIMH NIH HHS K23 MH114760
6 · The paper itself

Abstract

Pre-exposure prophylaxis (PrEP) implementation is underway across sub-Saharan Africa. However, little is known about health care providers' experiences with PrEP provision in generalized epidemic settings, particularly outside of selected risk groups. In this study (NCT01864603), universal access to PrEP was offered to adolescents and adults at elevated risk during population-level HIV testing in rural Kenya and Uganda. Providers received training on PrEP prescribing and support from local senior clinicians. We conducted in-depth interviews with providers (

Indexed as

Anti-HIV AgentsHIV InfectionsPre-Exposure ProphylaxisAdolescentAdultAttitudeFemaleHumansKenyaUgandaAnti-HIV AgentsAfrica south of the Saharahealth personnelHIV preventionpre-exposure prophylaxis

Identifiers

PMID36201226
PMCPMC9595612

What OpenQuestion holds

Textmetadata
Read underepoch 390

Registered trials

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.